mRNA-derived Prostate Cancer Vaccine CV9104

A prostate cancer vaccine containing six messenger RNAs (mRNAs) encoding for antigens upregulated in prostate cancer, including mRNAs for prostate specific antigen (PSA), prostate specific membrane antigen (PSMA), prostatic acid phosphatase (PAP), and mucin 1 (MUC1), with potential antineoplastic and immunomodulating activities. Upon intradermal administration of mRNA-derived prostate cancer vaccine CV9104, this agent enters cells, the mRNAs are translated into the respective prostate specific antigens and may cause the immune system to mount a cytotoxic T lymphocyte response (CTL) against PSA-, PSMA-, PAP- and MUC1-expressing prostate tumor cells. The mRNAs used in this vaccine are modified to have enhanced translational potency and adjuvant activities. PSA, PSMA, PAP and MUC1 are frequently upregulated in prostate cancer cells; their expression in prostate cancer has been correlated with disease progression. (NCI Thesaurus)

YOU MAY ALSO LIKE

mRNA-Derived Prostate Cancer Vaccine CV9103

A prostate cancer vaccine containing mRNAs encoding prostate specific antigen (PSA), prostate specific membrane antigen (PSMA), prostate stem cell antigen (PSCA) and…

mRNA-derived Lung Cancer Vaccine CV9202

A non-small cell lung cancer (NSCLC) vaccine containing six modified mRNAs, which encode six different NSCLC associated antigens, with potential antitumor and…

mRNA Transport Gene

An RNA transport gene that encodes a protein specifically involved in the transport of mRNA.

mRNA Surveillance

mRNA Surveillance works within elaborate cellular mechanisms to ensure accurate gene expression by assessing suitable mRNA quality for translation and prevents the…

mRNA Expression

The synthesis or transcription of messenger RNA.

mRNA Export

Transport of messenger RNA from its nuclear site of transcription to the cytoplasm, where the message is translated into protein by…